Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses.

Abstract

The study aims to assess the use of menopausal hormone therapy beyond age 65 years and its health implications by types of estrogen/progestogen, routes of administration, and dose strengths.